Apollo Medical Holdings Inc (NASDAQ:AMEH) has been given a consensus broker rating score of 2.00 (Buy) from the one brokers that provide coverage for the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a buy recommendation.
Brokers have set a 1 year consensus target price of $25.00 for the company and are expecting that the company will post $0.13 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Apollo Medical an industry rank of 62 out of 256 based on the ratings given to related companies.
AMEH has been the subject of a number of research analyst reports. TheStreet upgraded Apollo Medical from a “d” rating to a “c-” rating in a research note on Friday, June 28th. ValuEngine cut Apollo Medical from a “buy” rating to a “hold” rating in a research note on Tuesday, August 20th. Finally, Zacks Investment Research cut Apollo Medical from a “hold” rating to a “strong sell” rating in a research note on Friday, August 9th.
In related news, insider Albert Waichow Young purchased 5,000 shares of Apollo Medical stock in a transaction that occurred on Wednesday, August 14th. The stock was bought at an average cost of $15.01 per share, for a total transaction of $75,050.00. Following the completion of the transaction, the insider now owns 916,446 shares in the company, valued at $13,755,854.46. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Thomas S. Lam purchased 17,200 shares of Apollo Medical stock in a transaction that occurred on Thursday, August 15th. The shares were bought at an average price of $16.32 per share, with a total value of $280,704.00. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 31,200 shares of company stock valued at $508,344. 11.83% of the stock is owned by company insiders.
A number of institutional investors and hedge funds have recently modified their holdings of AMEH. SG Americas Securities LLC acquired a new stake in Apollo Medical in the first quarter valued at approximately $106,000. Strs Ohio grew its holdings in Apollo Medical by 7.7% in the second quarter. Strs Ohio now owns 15,400 shares of the company’s stock valued at $257,000 after purchasing an additional 1,100 shares during the period. Wells Fargo & Company MN grew its holdings in Apollo Medical by 23.4% in the second quarter. Wells Fargo & Company MN now owns 32,722 shares of the company’s stock valued at $547,000 after purchasing an additional 6,215 shares during the period. JPMorgan Chase & Co. grew its holdings in Apollo Medical by 113.7% in the second quarter. JPMorgan Chase & Co. now owns 1,733 shares of the company’s stock valued at $28,000 after purchasing an additional 922 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its holdings in Apollo Medical by 52.4% in the second quarter. Charles Schwab Investment Management Inc. now owns 19,822 shares of the company’s stock valued at $332,000 after purchasing an additional 6,816 shares during the period. 7.93% of the stock is currently owned by institutional investors.
Shares of AMEH stock traded down $0.10 during mid-day trading on Friday, reaching $20.67. 4,032 shares of the company’s stock traded hands, compared to its average volume of 167,321. Apollo Medical has a 12 month low of $13.36 and a 12 month high of $23.32. The company has a market cap of $726.97 million, a P/E ratio of 71.17, a P/E/G ratio of 12.27 and a beta of -0.95. The company has a quick ratio of 2.14, a current ratio of 2.14 and a debt-to-equity ratio of 0.30. The company’s 50-day moving average price is $17.58 and its 200-day moving average price is $17.74.
Apollo Medical (NASDAQ:AMEH) last announced its earnings results on Friday, August 9th. The company reported $0.09 EPS for the quarter, beating the Zacks’ consensus estimate of $0.05 by $0.04. Apollo Medical had a net margin of 1.94% and a return on equity of 5.28%. The firm had revenue of $130.05 million for the quarter. Equities analysts predict that Apollo Medical will post 0.33 earnings per share for the current year.
About Apollo Medical
Apollo Medical Holdings, Inc, a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.